🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Shape the future of cannabis education and medical applications with us! Explore new advancements. #MedicalCannabis #CannabisEducation #HempResearch #CannabisCommunity - CannabisResearchConference.net

Researchers at the Center for Medicinal Cannabis Research have found that CBD could help reduce problematic behaviors in autistic boys, providing insights into the potential benefits and limitations of CBD as a therapeutic intervention for autism. 📰 tinyurl.com/p7znfdv5

📢 New Study: Maternal Cannabis Use Disorder & Child Anxiety 🔹 Design: population-based linked cohort 🔹 N = 223,068 mother–child pairs 🔹 Findings: prenatal CUD ↑ any anxiety (aRR 1.79) & PTSD (2.46); postnatal CUD ↑ anxiety (2.02) 🔹 Confounds handled via mediation & PSM ✅

🎙️ New Episode Alert! 🎙️ In this episode of High5, Dr. Grant and Dr. Dale Gieringer spotlight a major roadblock in cannabis science: federal restrictions prevent researchers from studying the very cannabis products consumers legally use. 🧪🚫 Edibles, vapes, beverages—all

🎙️ New Episode Alert! 🎙️ In this episode of High5, Dr. Grant talks with Dr. Dale Gieringer about the groundbreaking work of Dr. Tod Mikuriya—a licensed psychiatrist who documented over 200 medical conditions for which patients reported cannabis provided relief. 📋🌿 From

🎙️ New Episode Alert! 🎙️ In this episode of High5, Dr. Grant and Dr. Dale Gieringer revisit NORML’s historic 1972 lawsuit to reschedule cannabis. ⚖️ After 19 years of legal battles, even with an administrative judge declaring cannabis “as safe as aspirin,” the DEA overruled the

🎙️ New Episode Alert! 🎙️ In this episode of High5, Dr. Grant and Dr. Dale Gieringer discuss how San Francisco’s organized gay community played a pivotal role in the medical cannabis movement. 🏳️‍🌈🌿 Amid the AIDS crisis, cancer, and glaucoma treatment challenges, marijuana became a

New Episode Alert! 🎙️ In this episode of High5, Dr. Grant talks with Dr. Dale Gieringer about the origins of NORML, founded in 1970s DC by public interest lawyer Keith Stroup. ⚖️ Backed by Ralph Nader, NORML quickly joined the push to reschedule cannabis—just as Nixon’s own

🎙️ New Episode Alert! 🎙️ In this episode of High5, Dr. Grant and Dr. Dale Gieringer spotlight a major roadblock in cannabis science: federal restrictions prevent researchers from studying the very cannabis products consumers legally use. 🧪🚫 Edibles, vapes, beverages—all

🎙️ New Episode Alert! 🎙️ In this episode of High5, Dr. Grant sits down with Dr. Dale Gieringer to revisit a pivotal moment in cannabis history – Dennis Peron’s 1991 San Francisco medical marijuana initiative. 🗳️ It passed with 80% of the vote and helped launch a movement.

🌿 Join us in Denver for SCC’s 3rd Annual Medical Cannabis Conference — where science meets healing. 🧠🍄 OCT 24–25 Denver, Colorado cannabisclinicians.org #medcancon25

📣 New Study: CBD vs THC & Inflammation 🔹 Design: pooled plasma data from multiple human studies 🔹 Sample: adults using high-CBD vs high-THC cannabis 🔹 Outcome: eicosanoids (LOX, COX, CYP450) 🔹 Key finding: high-CBD ↑ anti-inflammatory lipoxins & 15-LOX products; THC showed

🔹Register Now: CMCR Symposium🔹 ✅ Virtual, Oct 16–17 (8AM–12PM PT) ✅ Exploring paradoxes of cannabis & cannabinoids along gut-brain axis ✅ Abstracts due Sept 2 for oral poster session ➡️ Free CME credits available! 📌 tr.ee/TJB4b3 #MedicalCannabis

📢 New Study: Cannabigerol & Fear vs Pain 🔹 Design: mouse contextual-fear, tail-flick & rotarod tests 🔹 Subjects: male + female C57BL/6J mice, CBG 3-30 mg/kg 🔹 Findings: no effect on fear memory ✅; biphasic pain response in females (↑ latency at 3 mg/kg, ↓ at 30 mg/kg); no

🧠 New Research: CBD for Alcohol Use Disorder 🔹 Preclinical study using rodent models (CIE + EVSA) 🔹 Chronic CBD (30–60 mg/kg) reduced withdrawal, relapse, & drinking 🔹 Normalized amygdala activity & prevented striatal damage 🔹 CBD did not increase sedation or affect sugar

🫀 Cannabis and the Heart: What Clinicians Need to Know In our new article, Dr. Jahan Marcu unpacks the risks, realities, and clinical considerations for patients and healthcare providers. open.substack.com/pub/societyofc…

📄 Letter to the Editor: Are Cannabis ICD Codes Accurate for Classifying Cannabis Use? In a recently published letter to the editor of JACC: Advances (JACC Journals), authors—including Drs. Jamie Corroon ND MPH  and cmcr_director from Center for Medicinal Cannabis Research (CMCR) —urge better exposure classification,

Dr. Igor Grant, Director (cmcr_director) of the Center for Medicinal Cannabis Research (CMCR), was featured in a recent KPBS News article about how San Diego scientists are decoding the cannabis genome to uncover its therapeutic potential. Read the article here: f.mtr.cool/eoopuzdkgp

New Analysis: Cannabis Prescribing Patterns in Israel 🔹 Design: Retrospective cohort, single-site clinic (2021–2025) 🔹 Sample: 263 patients aged ≥30 🔹 Findings:  ✅ GI patients received highest doses  ✅ Males prescribed more THC  ✅ Neurological group preferred oil 🔹

Recent Analysis: Cannabis Use Trends in the U.S. (1979–2022) 🔹 Design: Secondary analysis of 27 national surveys 🔹 Data: NSDUH & predecessors (n = 1.64M) 🔹 2022: Past-year use = 12.6%, past-month = 10.1% 🔹 Daily or near daily use rose 15× since 1992—now exceeds alcohol 🔹